May 29, 2024
  • Ghana became the first country to approve a new malaria vaccineR21/Matrix-M vaccine – developed at Oxford University.
  • It is being manufactured by Serum Institute of India.
  • It has exceeded the WHO target of 75% efficacy.
  • However, WHO is yet to recommend the R21 vaccine for widespread use.
  • WHO has earlier approved RTS,S malaria vaccine in 2021.
    • It acts against Plasmodium falciparum.
  • There are 5 Plasmodium parasite species that cause malaria in humans and 2 of these species – falciparum and P. vivax – pose the greatest threat.
  • Malaria kills more than 600,000 people each year, most of them children in Africa.
Print Friendly, PDF & Email

© 2024 Civilstap Himachal Design & Development